| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥30.38B | ¥30.38B | +0.0% |
| Cost of Sales | ¥16.67B | ¥16.61B | +0.4% |
| Gross Profit | ¥13.71B | ¥13.76B | -0.4% |
| SG&A Expenses | ¥10.55B | ¥10.49B | +0.6% |
| Operating Income | ¥3.16B | ¥3.27B | -3.6% |
| Non-operating Income | ¥347M | ¥301M | +15.3% |
| Non-operating Expenses | ¥174M | ¥390M | -55.4% |
| Ordinary Income | ¥3.33B | ¥3.18B | +4.6% |
| Profit Before Tax | ¥2.77B | ¥3.18B | -12.7% |
| Income Tax Expense | ¥1.06B | ¥1.40B | -24.4% |
| Net Income | ¥1.72B | ¥1.78B | -3.6% |
| Net Income Attributable to Owners | ¥1.70B | ¥1.77B | -3.7% |
| Total Comprehensive Income | ¥1.96B | ¥840M | +133.6% |
| Interest Expense | ¥146M | ¥174M | -16.1% |
| Earnings per Unit (EPU) | ¥62.25 | ¥64.38 | -3.3% |
| Diluted Earnings per Unit | ¥62.19 | ¥64.32 | -3.3% |
| Distribution per Unit (DPU) | ¥20.00 | ¥20.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥51.17B | ¥51.67B | ¥-498M |
| Cash and Deposits | ¥13.82B | ¥13.35B | +¥473M |
| Accounts Receivable | ¥13.47B | ¥16.57B | ¥-3.10B |
| Inventories | ¥10.96B | ¥9.76B | +¥1.21B |
| Non-current Assets | ¥18.13B | ¥17.34B | +¥794M |
| Item | Value |
|---|---|
| Net Profit Margin | 5.6% |
| Gross Profit Margin | 45.1% |
| Current Ratio | 228.3% |
| Quick Ratio | 179.4% |
| Debt-to-Equity Ratio | 0.57x |
| Interest Coverage Ratio | 21.62x |
| Effective Tax Rate | 38.1% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +0.0% |
| Operating Income YoY Change | -3.6% |
| Ordinary Income YoY Change | +4.6% |
| Net Income Attributable to Owners YoY Change | -3.7% |
| Total Comprehensive Income YoY Change | +133.4% |
| Item | Value |
|---|---|
| Units Outstanding (incl. Treasury) | 27.85M shares |
| Treasury Units | 458K shares |
| Average Units Outstanding | 27.37M shares |
| NAV per Unit | ¥1,613.81 |
| Item | Amount |
|---|---|
| Q2 Distribution | ¥20.00 |
| Year-End Distribution | ¥20.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| AmericaMeasuringInstruments | ¥2.41B | ¥-1M |
| AmericaMedicalAndHealthSystem | ¥5.13B | ¥139M |
| AsiaAndOceaniaMeasuringInstruments | ¥4.60B | ¥328M |
| AsiaAndOceaniaMedicalAndHealthSystem | ¥3.98B | ¥85M |
| EuropeMeasuringInstruments | ¥285M | ¥-14M |
| EuropeMedicalAndHealthSystem | ¥4.42B | ¥24M |
| JapanMeasuringInstruments |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥70.00B |
| Operating Income Forecast | ¥9.50B |
| Ordinary Income Forecast | ¥9.40B |
| Net Income Attributable to Owners Forecast | ¥6.50B |
| Earnings per Unit Forecast (EPU) | ¥237.45 |
| Distribution per Unit Forecast (DPU) | ¥25.00 |
| Property, Plant & Equipment | ¥13.57B | ¥12.88B | +¥693M |
| Intangible Assets | ¥1.35B | ¥1.34B | +¥15M |
| Goodwill | ¥0 | ¥3M | ¥-3M |
| Total Assets | ¥69.30B | ¥69.00B | +¥295M |
| Current Liabilities | ¥22.41B | ¥22.78B | ¥-366M |
| Accounts Payable | ¥3.87B | ¥3.97B | ¥-103M |
| Short-term Loans | ¥10.46B | ¥10.81B | ¥-349M |
| Non-current Liabilities | ¥2.69B | ¥3.43B | ¥-739M |
| Long-term Loans | ¥254M | ¥1.27B | ¥-1.01B |
| Total Liabilities | ¥25.10B | ¥26.21B | ¥-1.11B |
| Total Equity | ¥44.20B | ¥42.80B | +¥1.40B |
| Capital Stock | ¥6.39B | ¥6.39B | ¥0 |
| Capital Surplus | ¥8.35B | ¥8.35B | ¥0 |
| Retained Earnings | ¥29.98B | ¥28.83B | +¥1.15B |
| Treasury Stock | ¥-431M | ¥-446M | +¥15M |
| Owners' Equity | ¥44.12B | ¥42.71B | +¥1.40B |
| Working Capital | ¥28.76B | - | - |
| ¥9.90B |
| ¥366M |
| JapanMedicalAndHealthSystem | ¥8.08B | ¥1.46B |
| JapanSemiconductorRelated | ¥5.08B | ¥1.57B |
| MeasuringInstruments | ¥17.19B | ¥679M |
| MedicalAndHealthSystem | ¥21.61B | ¥1.71B |